Skip to main content
SpringerLink
Log in

Radikale Zystektomie oder trimodale Therapie beim Blasenkarzinom: Wo stehen wir?

Radical cystectomy or trimodal therapy for bladder cancer: where do we stand?

  • Journal Club
  • Published:
Die Urologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Huddart RA, Hall E, Lewis R, Birtle A (2010) SPARE Trial Management Group. Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed. BJU Int 106:753–755

    Article  PubMed  Google Scholar 

  2. Vashistha V, Wang H, Mazzone A et al (2017) Radical cystectomy compared to combined modality treatment for muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 97:1002–1020

    Article  PubMed  Google Scholar 

  3. Seisen T, Sun M, Lipsitz SR et al (2017) Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder. Eur Urol 72:483–487

    Article  PubMed  Google Scholar 

  4. https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Blasenkarzinom/LL_Harnblasenkarzinom_Langversion_1.1.pdf. Zugegriffen: 23. Juli 2023

  5. Efstathiou JA, Bae K, Shipley WU et al (2009) Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol 27:4055–4061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kong V, Hansen VN, Hafeez S (2021) Image-guided adaptive radiotherapy for bladder cancer. Clin Oncol 33:350–368

    Article  CAS  Google Scholar 

  7. Efstathiou JA, Mouw KW, Gibb EA et al (2019) Impact of immune and stromal infiltration on outcomes following bladder-sparing trimodality therapy for muscle-invasive bladder cancer. Eur Urol 76:59–68

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Onkologie, Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland

    Claus Rödel

Authors
  1. Claus Rödel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus Rödel.

Ethics declarations

Interessenkonflikt

C. Rödel gibt an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rödel, C. Radikale Zystektomie oder trimodale Therapie beim Blasenkarzinom: Wo stehen wir?. Urologie 62, 1088–1089 (2023). https://doi.org/10.1007/s00120-023-02194-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-023-02194-2

Search

Navigation